Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timolol versus placebo to prevent regression after myopic LASIK
ChiCTR-TRC-14004839Phase 4Not yet recruiting
- Sponsor
- The Chinese University of Hong Kong
- Start
- Jan 1990
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of timolol in ametropia, myopia and myopic astigmatism (2 arms), sponsored by The Chinese University of Hong Kong. Primary endpoints: Spherical equivalent and Uncorrected visual acuity. Planned start Jan 1990; status: not yet recruiting.
02
Drugs
timolol
03
Conditions
ametropiamyopiamyopic astigmatism
Beyond the preview
Go deeper on ChiCTR-TRC-14004839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004839.